L. Jacobsson

20.7k citations
339 papers · 16.0k · 3 hit papers · h-index 62

Impact in

  • Rheumatology top 0.05%
    • Rheumatoid Arthritis Research and Therapies
    • Spondyloarthritis Studies and Treatments
    • Systemic Lupus Erythematosus Research
  • Nephrology top 0.2%
    • Gout, Hyperuricemia, Uric Acid

Papers in

    • Rheumatoid Arthritis Research and Therapies 104
    • Spondyloarthritis Studies and Treatments 80
    • Systemic Lupus Erythematosus Research 14
    • Gout, Hyperuricemia, Uric Acid 31

L. Jacobsson

334 papers receiving 15.4k citations

L. Jacobsson's Hit Papers

Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors 2020 · 958 citations
9580+10+21Years since publication250500750

Peers

L. Jacobsson
Comparison fields: 5 of 163
  • Rheumatology 6.9k
  • Nephrology 1.6k
  • Hematology 1.1k
  • Immunology 1.7k
  • Physiology 1.7k
Replace David A. Roth with:
David A. Roth United States
Michael W. Walsh Canada
Gere Sunder–Plassmann Austria
Joseph F. Polak United States
Daniel H. O’Leary United States
Ichiei Narita Japan
Jacques P. Brown Canada
Richard J. Glassock United States
Paolo Raggi United States
Peter F. Barany Sweden
L. Jacobsson relative to David A. Roth United States David A. Roth's profile →
Citations per field
00.5×1.5×1.9×
David A. Roth · 1×
Citations per year

Countries citing papers authored by L. Jacobsson

Since Specialization
Citations

This map shows the geographic impact of L. Jacobsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Jacobsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Jacobsson more than expected).

Fields of papers citing papers by L. Jacobsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Jacobsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Jacobsson. The network helps show where L. Jacobsson may publish in the future.

Co-authors

The 25 scholars most cited alongside L. Jacobsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L. Jacobsson Line = papers co-authored together L. Jacobsson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 339 papers — load more, or switch the sort, to bring in the rest.

#Work
1
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
Hit paper breakdown →
2016997
2
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
Hit paper breakdown →
2020958
3
Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype?
Hit paper breakdown →
1994569
4
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
2005455
5
Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study.
2001448
6 1994394
7 2005345
8 2007283
9 2008223
10 2009223
11 2004217
12 2009207
13 2007197
14 2006182
15
Chronic widespread pain: a three year followup of pain distribution and risk factors.
2002163
16 2004146
17 1989143
18 1993143
19 2004141
20
The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events
1996135

About L. Jacobsson

L. Jacobsson is a scholar working on Rheumatology, Nephrology, Physiology, Immunology and Pulmonary and Respiratory Medicine, having authored 339 papers that have together received 16.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (104 papers), Spondyloarthritis Studies and Treatments (80 papers), Salivary Gland Disorders and Functions (32 papers), Gout, Hyperuricemia, Uric Acid (31 papers), Systemic Lupus Erythematosus Research (14 papers), Psoriasis: Treatment and Pathogenesis (11 papers), Vasculitis and related conditions (10 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (10 papers). The work is most often cited by research in Rheumatology (6.9k citations), Nephrology (1.6k citations), Hematology (1.1k citations), Immunology (1.7k citations) and Physiology (1.7k citations). L. Jacobsson has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Ingemar F. Petersson, Mats Dehlin, Carl Turesson, Johan Askling, Edward Roddy, R. Manthorpe, Robert L. Hanson, William C. Knowler, Tore Saxne and Peter H. Bennett. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Research & Therapy, Scandinavian Journal of Rheumatology and The Journal of Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact